Evidence map›Paper›PMID 41333839›Full record

ReviewJournal of pharmaceutical analysis2025

Recent trends in mesoporous carbon-based nanoplatforms for biomedical application.

Wei Yang, Jinnian Ge, Mohan Jiang, Nan Zhang, Qinghe Yang, Kaisheng Nan, Qinfu Zhao, Long Wan, Xiaofan Wang

Abstract readReview
In one paragraph

Review in Journal of pharmaceutical analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei YangDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Jinnian GeDepartment of General Surgery, The First Hospital of China Medical University, Shenyang, 110001, China.
Mohan JiangDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, 110001, China.
Nan ZhangDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, China.
Qinghe YangDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, China.
Kaisheng NanDepartment of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Qinfu ZhaoDepartment of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Long WanDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, China.
Xiaofan WangSchool of Pharmacy, China Medical University, Shenyang, 110122, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesoporous carbon nanoparticles (MCNs) have received considerable attention for biomedical applications due to their unique structural features, including high specific surface area, adjustable pore size, and remarkable biocompatibility. These properties have addressed key challenges such as inefficiencies in drug loading and release, minimizing the side effects associated with conventional treatments. In this review, the classification and the research progress of MCNs are summarized firstly, the preparation and modification techniques to enhance their functionality and properties are further reviewed, the main physicochemical properties are introduced as well, highlighting their contributions to MCNs in applications. In addition, the biomedical applications of MCNs are emphasized, including tumor therapy, tumor theranostics, antibacterial, delivery of active molecules and biological detection. Finally, the prospects and challenges of clinical application based on MCNs are analyzed to provide an effective reference and lay the foundation for further research.

Indexed as

AntibacterialBiological detectionBiomedical applicationMesoporous carbon-based nanocompositesTumor theranostics

Identifiers

PMID41333839
PMCPMC12666858

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.